Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Conditions: Osteosarcoma

First Posted Date: 2020-09-30

Last Posted Date: 2025-03-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT04571229

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

Early Phase 1

Completed

Conditions: Large B-cell Lymphoma
DLBCL

Interventions: Drug: 89Zr-DFO-REGN3767
Diagnostic Test: PET/CT

First Posted Date: 2020-09-28

Last Posted Date: 2025-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT04566978

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies

Phase 1

Withdrawn

Conditions: Lymphoma
Leukemia
Lymphoma, B-Cell

Interventions: Biological: CAR T-Cell Infusion

First Posted Date: 2020-09-21

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT04556266

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma

Phase 1

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Biological: Infusion of MCARH109 T cells

First Posted Date: 2020-09-18

Last Posted Date: 2025-03-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT04555551

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison, New York, United States

and more 4 locations

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Phase 2

Active, not recruiting

Conditions: Solid Tumor
Solid Carcinoma
Solid Tumor, Adult
Hematologic Malignancy

Interventions: Drug: Benralizumab

First Posted Date: 2020-09-17

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT04552288

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center Suffolk - Hauppauge (Limited Protocol Activities), Hauppauge, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States

and more 2 locations

Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma

Phase 2

Completed

Conditions: Basal Cell Cancer
Superficial Basal Cell Carcinoma
BCC
BCC - Basal Cell Carcinoma
Basal Cell Carcinoma
Nodular Basal Cell Carcinoma

Interventions: Drug: Jet injection of ALA
Procedure: Surgical excision
Other: Incubation
Procedure: Illumination

First Posted Date: 2020-09-17

Last Posted Date: 2025-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT04552990

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Safety of Lung Cryobiopsy in People With Cancer

Phase 2

Active, not recruiting

Conditions: Lung Cancer

Interventions: Procedure: Transbronchial cryobiopsy

First Posted Date: 2020-09-16

Last Posted Date: 2025-05-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 100

Registration Number: NCT04548830

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Neurocutaneous Melanocytosis Registry

Recruiting

Conditions: Neurocutaneous Melanocytosis
Cutaneous Melanocytic Neoplasm
Large Cutaneous Melanocytic Nevi

First Posted Date: 2020-09-16

Last Posted Date: 2025-04-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 75

Registration Number: NCT04548817

Locations: 🇺🇸
Boston Children's Hospital (Data Analysis Only), Boston, Massachusetts, United States
🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

Early Phase 1

Active, not recruiting

Conditions: Neuroendocrine Tumors
Liver-Dominant Metastatic Pancreatic Neuroendocrine Tumors

Interventions: Drug: 177Lu-DOTATATE

First Posted Date: 2020-09-10

Last Posted Date: 2025-05-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT04544098

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Phase 2

Active, not recruiting

Conditions: Thyroid Cancer, Follicular
Poorly Differentiated Thyroid Gland Carcinoma
Thyroid Cancer
Hurthle Cell Thyroid Neoplasia
Papillary Thyroid Cancer
Follicular Thyroid Cancer
Hurthle Cell Tumor

Interventions: Drug: Trametinib
Drug: Dabrafenib
Drug: PDR001

First Posted Date: 2020-09-10

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 19

Registration Number: NCT04544111

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy